Mirum Pharmaceuticals, Inc.MIRMNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$54.87M
↑ 201% vs avg
Percentile
P100
Near historical high
Streak
4 yr
Consecutive growthExpanding
Average
$-54.48M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $54.87M | +488.0% |
| 2024 | $9.33M | +110.2% |
| 2023 | $-91.05M | +24.4% |
| 2022 | $-120.41M | +20.7% |
| 2021 | $-151.78M | -70.0% |
| 2020 | $-89.30M | -125.3% |
| 2019 | $-39.64M | -403.5% |
| 2018 | $-7.87M | - |